Podcast PX Pulse
PxPulse: The Votes are In — What’s next for the US’ role in global health and HIV prevention
KFF’s Jen Kates and AVAC’s Suraj Madoori lay out the challenges and the priorities in 2025 and beyond.
In the days, months and years ahead under a new US Presidential Administration, advocacy for choice, freedom, science, and rights will require intentional strategies to protect hard fought gains in HIV treatment and prevention and in global health generally, and to safeguard policies and programs that advance it. And there will be major implications for the global AIDS response.
Navigating through the work ahead involves assessing the potential impact on PEPFAR and Global Fund support; on USAID, NIH, CDC and the FDA; on the US relationship to WHO and other UN agencies; and on evidence- and rights-based policies and programs generally. Joining us to begin those efforts and better understand the landscape for advocacy are Jen Kates from KFF and our own Suraj Madoori.
Listen
Resources
- Donald Trump won. What does that mean for development? Devex
- KFF Tracker: US Pledges to Upcoming Multilateral Health Replenishments
- PEPFAR: Exploring Co-Financing as a Tool for Domestic Resource Mobilization , KFF
- The Mexico City Policy: An Explainer, KFF
- Will Trump gut UN family planning funds … again?, Devex
Subscribe to this Podcast
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!